103 computer-programmer-"https:"-"CEA-Saclay" "https:" "https:" "https:" "https:" "https:" "Dr" "UCL" Postdoctoral positions at University of Washington in United States
Sort by
Refine Your Search
-
Position Summary A postdoctoral position (Ph.D. or M.D./Ph.D.) is available in the laboratory of Dr. Erica Schmitt in the Department of Pediatrics, Division of Rheumatology/Immunology at WashU
-
Position Summary WashU Medicine, Department of Neurology, has an opening for a Postdoctoral Research Associate to join the NeuroGenomics and Informatics Center (NGI). The successful candidate will
-
against bacterial infections. Dr. Morley is a physician scientist with a clinical subspecialty in Pediatric Infectious Diseases and with a keen interest in effective host immunity against Streptococcus
-
Primary Duties & Responsibilities: Information on being a postdoc at WashU in St. Louis can be found at https://postdoc.wustl.edu/prospective-postdocs-2/ . Trains under the supervision of a faculty mentor
-
found at https://postdoc.wustl.edu/prospective-postdocs-2/ . Trains under the supervision of a faculty mentor including (but not limited to): Manages their own project, which should lead to a first
-
, genetics, biochemistry, functional assessments, and immunolabeling. Job Description Primary Duties & Responsibilities: Information on being a postdoc at WashU in St. Louis can be found at https
-
at WashU in St. Louis can be found at https://postdoc.wustl.edu/prospective-postdocs-2/ . Trains under the supervision of a faculty mentor including (but not limited to): Assists with grant
-
polymers for soft electronic devices. Job Description Primary Duties & Responsibilities: You can learn more about our research at https://coopergroup.wustl.edu/ . Information on being a postdoc at WashU in
-
, epigenetics, and metabolism. Job Description Primary Duties & Responsibilities: Information on being a postdoc at WashU in St. Louis can be found at https://postdoc.wustl.edu/prospective-postdocs-2/ . Trains
-
role in immune modulation. In addition, the lab also has a robust program in development of small molecule inhibitors as therapeutic option for these cancers. The lab has previously identified multiple